B+
Bull case
25%
Probability
Target price
$260.00
Analysis reference price unavailable
Analysis 2026-10-26 · RankAlpha Sentiment Codex
MOH
Molina HealthcareBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$215.00
Analysis reference price unavailable
Analysis 2026-10-26 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$160.00
Analysis reference price unavailable
Analysis 2026-10-26 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-26
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+66.4
Score
AI commentary
Tone remains mixed despite the Q3 beat: the packet's October 23 anchor is $209.15, and Benzinga reports a 3.46% decline that day. The earnings-call coverage also reports an initial post-release premarket decline, linking concern to the softer 2027 outlook and Florida costs. Analyst target changes are mixed, and the packet supplies no usable social, options, short-interest, or employee measures; the zero placeholders above do not imply neutral readings.
RankAlpha Sentiment Codex - 2026-10-26
Open post-earnings memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators
Impact
tentative
Confidence
-
AI events
2026-10-23eventQ3 beat met a weaker forward outlookMedium impact
Molina reported $0.89 adjusted EPS and $11.08 billion revenue, above the $0.79 and $10.86 billion estimates reported by Investing.com. It reaffirmed at least $5.25 of 2026 adjusted EPS, but adjusted EPS fell from $1.84 a year earlier and consolidated medical cost ratio rose to 92.9% [#8-K-2026-10-21] [#SEC-8K-2026-10-21] company earnings exhibit. The earnings-call transcript reports a reduction in preliminary 2027 premium guidance to at least $45 billion from $46.5 billion because Georgia and Texas contract starts were delayed.
2026-12-31catalystFlorida Medicaid contract tests fourth-quarter earningsMedium impact
Molina's reaffirmed 2026 guidance includes a $1.50-per-share loss from implementing its new Florida Medicaid contract in Q4. The size of that drag makes the ramp an execution test rather than immediate evidence of earnings recovery [#8-K-2026-10-21] company earnings exhibit.
2027-01-01catalyst2027 Medicaid rate cycle could restore marginsHigh impact
Management said elevated medical-cost trends may be plateauing and stronger 2027 rate updates could mark the beginning of a Medicaid margin turn [#8-K-2026-10-21] company earnings exhibit. The earnings-call transcript describes approximately 7% draft increases on the known portion of January 1 renewals, but actual margin recovery still depends on medical-cost trend and member mix.
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-26 • Updated nightlySource: Internal modelMethodology